| 1 |
Yang Z, Wang L, Zhang J, Liu J, Yu X. Application of bismuth sulfide based nanomaterials in cancer diagnosis and treatment. Nano Today 2023;49:101799. [DOI: 10.1016/j.nantod.2023.101799] [Reference Citation Analysis]
|
| 2 |
Qin J, Pan C. Synthesis, structure and optical properties of (H2DMAPA)BiBr5, (H2DMAPA)BiBr2I3, (H2DMAPA)2AgBiBr8 and (H2EP)2AgBiBr8 lead-free perovskites. Journal of Solid State Chemistry 2023. [DOI: 10.1016/j.jssc.2023.123938] [Reference Citation Analysis]
|
| 3 |
Liu P, Xiao Y, Yang Z, Yu S, Meng X. Two-dimensional hybrid double perovskite (PA)4AgBiBr8 single crystals for X-ray detection. Optical Materials 2022;133:112972. [DOI: 10.1016/j.optmat.2022.112972] [Reference Citation Analysis]
|
| 4 |
Zelepukin IV, Ivanov IN, Mirkasymov AB, Shevchenko KG, Popov AA, Prasad PN, Kabashin AV, Deyev SM. Polymer-coated BiOCl nanosheets for safe and regioselective gastrointestinal X-ray imaging. J Control Release 2022;349:475-85. [PMID: 35839934 DOI: 10.1016/j.jconrel.2022.07.007] [Reference Citation Analysis]
|
| 5 |
Wang R, Chan JF, Wang S, Li H, Zhao J, Ip TK, Zuo Z, Yuen K, Yuan S, Sun H. Orally administered bismuth drug together with N -acetyl cysteine as a broad-spectrum anti-coronavirus cocktail therapy. Chem Sci . [DOI: 10.1039/d1sc04515f] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 6 |
Himeno S, Fujishiro H, Sumi D. Bismuth. Handbook on the Toxicology of Metals 2022. [DOI: 10.1016/b978-0-12-822946-0.00005-2] [Reference Citation Analysis]
|
| 7 |
Ghasemi M, Hao M, Xiao M, Chen P, He D, Zhang Y, Chen W, Fan J, Yun JH, Jia B, Wen X. Lead-free metal-halide double perovskites: from optoelectronic properties to applications. Nanophotonics 2021;10:2181-219. [DOI: 10.1515/nanoph-2020-0548] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 8 |
Tseng KH, Hsieh CL, Chung MY. Fabrication of nano-bismuth colloids in deionized water using an electrical discharge machine. Nanotechnology 2020;31:425704. [PMID: 32554871 DOI: 10.1088/1361-6528/ab9e28] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 9 |
Poddalgoda D, Hays SM, Nong A. Derivation of biomonitoring equivalents (BE values) for bismuth. Regul Toxicol Pharmacol 2020;114:104672. [PMID: 32418918 DOI: 10.1016/j.yrtph.2020.104672] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 10 |
Zhang Y, Fadaei Tirani F, Pattison P, Schenk-joß K, Xiao Z, Nazeeruddin MK, Gao P. Zero-dimensional hybrid iodobismuthate derivatives: from structure study to photovoltaic application. Dalton Trans 2020;49:5815-22. [DOI: 10.1039/d0dt00015a] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 11 |
Shor J, Churrango G, Hosseini N, Marshall C. Management of microscopic colitis: challenges and solutions. Clin Exp Gastroenterol 2019;12:111-20. [PMID: 30881078 DOI: 10.2147/CEG.S165047] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 12 |
Bogusz K, Cardillo D, Tehei M, Boutard T, Barker PJ, Devers T, Rosenfeld A, Dou SX, Liu HK, Konstantinov K. Biocompatible Bi(OH)3 nanoparticles with reduced photocatalytic activity as possible ultraviolet filter in sunscreens. Materials Research Bulletin 2018;108:130-41. [DOI: 10.1016/j.materresbull.2018.08.041] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 13 |
Cheng Y, Zhang H. Novel Bismuth-Based Nanomaterials Used for Cancer Diagnosis and Therapy. Chem Eur J 2018;24:17405-18. [DOI: 10.1002/chem.201801588] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 14 |
Bogusz K, Tehei M, Cardillo D, Lerch M, Rosenfeld A, Dou SX, Liu HK, Konstantinov K. High toxicity of Bi(OH)3 and α-Bi2O3 nanoparticles towards malignant 9L and MCF-7 cells. Mater Sci Eng C Mater Biol Appl 2018;93:958-67. [PMID: 30274133 DOI: 10.1016/j.msec.2018.09.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 15 |
Lahner E, Carabotti M, Annibale B. Treatment of Helicobacter pylori infection in atrophic gastritis. World J Gastroenterol 2018; 24(22): 2373-2380 [PMID: 29904244 DOI: 10.3748/wjg.v24.i22.2373] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 42] [Article Influence: 8.2] [Reference Citation Analysis]
|
| 16 |
Li L, Meng F, Zhu S, Guo S, Wang Y, Zhao X, Sun Y, Zhang Y, Wang Q, Xu H, Zhang S. Efficacy and Safety of Wei Bi Mei, a Chinese Herb Compound, as an Alternative to Bismuth for Eradication of Helicobacter pylori. Evid Based Complement Alternat Med. 2018;2018:4320219. [PMID: 29636776 DOI: 10.1155/2018/4320219] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 17 |
Liang L, Gao P. Lead-Free Hybrid Perovskite Absorbers for Viable Application: Can We Eat the Cake and Have It too? Adv Sci (Weinh) 2018;5:1700331. [PMID: 29610719 DOI: 10.1002/advs.201700331] [Cited by in Crossref: 175] [Cited by in F6Publishing: 180] [Article Influence: 35.0] [Reference Citation Analysis]
|
| 18 |
Bogusz K, Tehei M, Lerch M, Dou SX, Liu HK, Konstantinov K. TiO 2 /(BiO) 2 CO 3 nanocomposites for ultraviolet filtration with reduced photocatalytic activity. J Mater Chem C 2018;6:5639-50. [DOI: 10.1039/c8tc01330f] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 19 |
Omouri Z, Hawari J, Fournier M, Robidoux PY. Bioavailability and chronic toxicity of bismuth citrate to earthworm Eisenia andrei exposed to natural sandy soil. Ecotoxicology and Environmental Safety 2018;147:1-8. [DOI: 10.1016/j.ecoenv.2017.08.018] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 20 |
Rai M, Ingle AP, Pandit R, Paralikar P, Gupta I, Chaud MV, dos Santos CA. Broadening the spectrum of small-molecule antibacterials by metallic nanoparticles to overcome microbial resistance. International Journal of Pharmaceutics 2017;532:139-48. [DOI: 10.1016/j.ijpharm.2017.08.127] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 21 |
Rodríguez de Santiago E, Martín de Argila de Prados C, Marcos Prieto HM, Jorge Turrión MÃ, Barreiro Alonso E, Flores de Miguel A, de la Coba Ortiz C, Rodríguez Escaja C, Pérez Álvarez G, Ferre Aracil C, Aguilera Castro L, García García de Paredes A, Rodríguez Pérez A, Albillos Martínez A. Limited effectiveness with a 10-day bismuth-containing quadruple therapy (Pylera(®) ) in third-line recue treatment for Helicobacter pylori infection. A real-life multicenter study. Helicobacter 2017;22. [PMID: 28771880 DOI: 10.1111/hel.12423] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 22 |
Metal Complexes for Killing Parasites, Bacteria and Viruses. Metals in Medicine 2017. [DOI: 10.1002/9781119191377.ch7] [Reference Citation Analysis]
|
| 23 |
Kim SE, Park MI, Park SJ, Moon W, Kim JH, Jung K, Kim HK, Lee YD. Second-line bismuth-containing quadruple therapy for Helicobacter pylori eradication and impact of diabetes. World J Gastroenterol 2017; 23(6): 1059-1066 [PMID: 28246480 DOI: 10.3748/wjg.v23.i6.1059] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 24 |
Weber M, Schlesinger M, Walther M, Zahn D, Schalley CA, Mehring M. Investigations on the growth of bismuth oxido clusters and the nucleation to give metastable bismuth oxide modifications. Zeitschrift für Kristallographie - Crystalline Materials 2017;232:185-207. [DOI: 10.1515/zkri-2016-1970] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 25 |
Wei F, Deng Z, Sun S, Xie F, Kieslich G, Evans DM, Carpenter MA, Bristowe PD, Cheetham AK. The synthesis, structure and electronic properties of a lead-free hybrid inorganic–organic double perovskite (MA) 2 KBiCl 6 (MA = methylammonium). Mater Horiz 2016;3:328-32. [DOI: 10.1039/c6mh00053c] [Cited by in Crossref: 221] [Cited by in F6Publishing: 220] [Article Influence: 31.6] [Reference Citation Analysis]
|
| 26 |
Flores-castañeda M, Vega-jiménez AL, Almaguer-flores A, Camps E, Pérez M, Silva-bermudez P, Berea E, Rodil SE. Antibacterial effect of bismuth subsalicylate nanoparticles synthesized by laser ablation. J Nanopart Res 2015;17. [DOI: 10.1007/s11051-015-3237-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 27 |
Schlesinger M, Pathak A, Richter S, Sattler D, Seifert A, Rüffer T, Andrews PC, Schalley CA, Lang H, Mehring M. Salicylate‐Functionalized Bismuth Oxido Clusters: Hydrolysis Processes and Microbiological Activity. Eur J Inorg Chem 2014;2014:4218-27. [DOI: 10.1002/ejic.201402493] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 28 |
Delchier JC, Malfertheiner P, Thieroff-Ekerdt R. Use of a combination formulation of bismuth, metronidazole and tetracycline with omeprazole as a rescue therapy for eradication of Helicobacter pylori. Aliment Pharmacol Ther 2014;40:171-7. [PMID: 24863854 DOI: 10.1111/apt.12808] [Cited by in Crossref: 66] [Cited by in F6Publishing: 47] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 29 |
Hawksworth EL, Andrews PC, Lie W, Lai B, Dillon CT. Biological evaluation of bismuth non-steroidal anti-inflammatory drugs (BiNSAIDs): Stability, toxicity and uptake in HCT-8 colon cancer cells. Journal of Inorganic Biochemistry 2014;135:28-39. [DOI: 10.1016/j.jinorgbio.2014.02.012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 30 |
Aggarwal A, Bhatt M. Commonly used gastrointestinal drugs. Handb Clin Neurol 2014;120:633-43. [PMID: 24365343 DOI: 10.1016/B978-0-7020-4087-0.00043-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 31 |
Ward AJ, Rich AM, Masters AF, Maschmeyer T. Unprecedented blue-shift in bismuth oxide supported on mesoporous silica. New J Chem 2013;37:593-600. [DOI: 10.1039/c2nj40847c] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 32 |
Kromer W, Postius S, Krüger U, Ganellin CR. Antiulcer Drugs. Ullmann's Encyclopedia of Industrial Chemistry 2012. [DOI: 10.1002/14356007.a02_321.pub2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 33 |
Urgast DS, Ellingsen DG, Berlinger B, Eilertsen E, Friisk G, Skaug V, Thomassen Y, Beattie JH, Kwun IS, Feldmann J. Multi-elemental bio-imaging of rat tissue from a study investigating the bioavailability of bismuth from shotgun pellets. Anal Bioanal Chem 2012;404:89-99. [PMID: 22627704 DOI: 10.1007/s00216-012-6101-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 34 |
Wang Y, Tang N, Meng L, Zhang P, Xu K, Jiang N, Zhang H, Ou N, Wu D, Chen A, Zhang X, Shi R. Safety and tolerability of bismuthyl ecabet suspension, a novel anti-ulcer agent, following single and multiple oral dose administration in healthy Chinese subjects. Clin Drug Investig 2012;32:247-52. [PMID: 22299715 DOI: 10.2165/11599110-000000000-00000] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 35 |
Mansfeld D, Miersch L, Rüffer T, Schaarschmidt D, Lang H, Böhle T, Troff RW, Schalley CA, Müller J, Mehring M. From {Bi22O26} to Chiral Ligand-Protected {Bi38O45}-Based Bismuth Oxido Clusters. Chem Eur J 2011;17:14805-10. [DOI: 10.1002/chem.201102437] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 36 |
Sun Q, Liang X, Zheng Q, Liu W, Xiao S, Gu W, Lu H. High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication. Helicobacter 2010;15:233-8. [PMID: 20557366 DOI: 10.1111/j.1523-5378.2010.00758.x] [Cited by in Crossref: 77] [Cited by in F6Publishing: 79] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 37 |
Murata T. Bismuth solubility through binding by various organic compounds and naturally occurring soil organic matter. Journal of Environmental Science and Health, Part A 2010;45:746-53. [DOI: 10.1080/10934521003651465] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 38 |
Hirner AV, Rettenmeier AW. Methylated Metal(loid) Species in Humans. Organometallics in Environment and Toxicology 2010. [DOI: 10.1039/9781849730822-00465] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 39 |
Andrews PC, Deacon GB, Ferrero RL, Junk PC, Karrar A, Kumar I, MacLellan JG. Bismuth(III) 5-sulfosalicylate complexes: structure, solubility and activity against Helicobacter pylori. Dalton Trans 2009;:6377-84. [PMID: 19655072 DOI: 10.1039/b900774a] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 40 |
Ford AC, Malfertheiner P, Giguere M, Santana J, Khan M, Moayyedi P. Adverse events with bismuth salts for Helicobacter pylori eradication: systematic review and meta-analysis. World J Gastroenterol. 2008;14:7361-7370. [PMID: 19109870 DOI: 10.3748/wjg.v14.i48.7361] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 41 |
Ford AC, Malfertheiner P, Giguère M, Santana J, Khan M, Moayyedi P. Adverse events with bismuth salts for Helicobacter pylori eradication: Systematic review and meta-analysis. World J Gastroenterol 2008; 14(48): 7361-7370 [PMID: 19109870 DOI: 10.3748/wjg.14.7361] [Cited by in CrossRef: 83] [Cited by in F6Publishing: 90] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 42 |
Treiber G, Malfertheiner P, Klotz U. Treatment and dosing of Helicobacter pylori infection: when pharmacology meets clinic. Expert Opin Pharmacother 2007;8:329-50. [PMID: 17266468 DOI: 10.1517/14656566.8.3.329] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 43 |
Farnell MB, Donoghue AM, de Los Santos FS, Reyes-Herrera I, Cole K, Dirain ML, Blore PJ, Pandya K, Donoghue DJ. Effect of oral administration of bismuth compounds on Campylobacter colonization in broilers. Poult Sci 2006;85:2009-11. [PMID: 17032837 DOI: 10.1093/ps/85.11.2009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 44 |
Bonvin Y, Callens E, Larrosa I, Henderson DA, Oldham J, Burton AJ, Barrett AG. Bismuth-catalyzed benzylic oxidations with tert-butyl hydroperoxide. Org Lett 2005;7:4549-52. [PMID: 16209476 DOI: 10.1021/ol051765k] [Cited by in Crossref: 141] [Cited by in F6Publishing: 142] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 45 |
Murata T. Effects of Bismuth Contamination on the Growth and Activity of Soil Microorganisms Using Thiols as Model Compounds. Journal of Environmental Science and Health, Part A 2006;41:161-72. [DOI: 10.1080/10934520500349276] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 46 |
Zhang H, Tang J, Meng X, Tsang J, Tsang TK. Inhibition of bacterial adherence on the surface of stents and bacterial growth in bile by bismuth dimercaprol. Dig Dis Sci 2005;50:1046-51. [PMID: 15986852 DOI: 10.1007/s10620-005-2702-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 47 |
Zhang M, Gumerov DR, Kaltashov IA, Mason AB. Indirect detection of protein-Metal binding: Interaction of serum transferrin with In 3+ and Bi 3+. J Am Soc Mass Spectrom 2004;15:1658-64. [DOI: 10.1016/j.jasms.2004.08.009] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 48 |
Perri F, Villani MR, Quitadamo M, Annese V, Niro GA, Andriulli A. Ranitidine bismuth citrate-based triple therapies after failure of the standard 'Maastricht triple therapy': a promising alternative to the quadruple therapy? Aliment Pharmacol Ther 2001;15:1017-22. [PMID: 11421877 DOI: 10.1046/j.1365-2036.2001.01002.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 49 |
Phillips RH, Whitehead MW, Doig LA, Sieniawska CE, Delves HT, Thompson RP, Powell JJ. Is eradication of Helicobacter pylori with colloidal bismuth subcitrate quadruple therapy safe? Helicobacter 2001;6:151-6. [PMID: 11422471 DOI: 10.1046/j.1523-5378.2001.00022.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 50 |
Whitehead MW, Phillips RH, Sieniawska CE, Delves HT, Seed PT, Thompson RP, Powell JJ. Double-blind comparison of absorbable colloidal bismuth subcitrate and nonabsorbable bismuth subnitrate in the eradication of Helicobacter pylori and the relief of nonulcer dyspepsia. Helicobacter 2000;5:169-75. [PMID: 10971683 DOI: 10.1046/j.1523-5378.2000.00027.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 51 |
Kromer W, Postius S, Krüger U. Antiulcer Drugs. Ullmann's Encyclopedia of Industrial Chemistry 2000. [DOI: 10.1002/14356007.a02_321] [Reference Citation Analysis]
|
| 52 |
Mandel KG, Daggy BP, Brodie DA, Jacoby HI. Review article: alginate-raft formulations in the treatment of heartburn and acid reflux. Aliment Pharmacol Ther 2000;14:669-90. [PMID: 10848650 DOI: 10.1046/j.1365-2036.2000.00759.x] [Cited by in Crossref: 150] [Cited by in F6Publishing: 154] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 53 |
Peterson TC, Cleary CE, Shaw AM, Malatjalian DA, Veldhuyzen van Zanten SJ. Therapeutic role for bismuth compounds in TNBS-induced colitis in the rat. Dig Dis Sci 2000;45:466-73. [PMID: 10749319 DOI: 10.1023/a:1005476619923] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 54 |
Veldhuyzen Van Zanten S, Chiba N. What is the role of bismuth in Helicobacter pylori antimicrobial resistance? Helicobacter pylori 2000. [DOI: 10.1007/978-94-011-3927-4_64] [Reference Citation Analysis]
|
| 55 |
Bagchi D, McGinn TR, Ye X, Balmoori J, Bagchi M, Stohs SJ, Kuszynski CA, Carryl OR, Mitra S. Mechanism of gastroprotection by bismuth subsalicylate against chemically induced oxidative stress in cultured human gastric mucosal cells. Dig Dis Sci 1999;44:2419-28. [PMID: 10630491 DOI: 10.1023/a:1026618501729] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 56 |
Briand GG, Burford N. Bismuth compounds and preparations with biological or medicinal relevance. Chem Rev 1999;99:2601-58. [PMID: 11749495 DOI: 10.1021/cr980425s] [Cited by in Crossref: 488] [Cited by in F6Publishing: 488] [Article Influence: 20.3] [Reference Citation Analysis]
|
| 57 |
Mönkemüller, Hirschowitz. Prospective evaluation of ranitidine bismuth citrate-based triple therapy for the treatment of Helicobacter pylori infection. Alimentary Pharmacology & Therapeutics 1999;13:661-665. [DOI: 10.1046/j.1365-2036.1999.00509.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 58 |
Dahlgren A, Gløgård C, Gammelsaether M, Aasen AJ, Klaveness J, Berdal BP, Bergan T. Organobismuth compounds: activity against Helicobacter pylori. Scand J Gastroenterol 1999;34:135-7. [PMID: 10192189 DOI: 10.1080/00365529950172970] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 59 |
von Bruchhausen F, Ebel S, Hackenthal E, Holzgrabe U, Albinus M, Amschler G, von Angerer E, Arras-reiter C, Bauer A, Bauer P, Beil W, Beyrich T, Binder K, Böhme R, Borchert H, Bossle F, Bracher F, Bräunlich H, Bretschneider E, Brigelius-flohé R, Brinkmann K, Büge A, Christ W, Cimbollek M, Daniels R, Dannhardt G, Duchstein H, Eger K, Eichhorn P, Engler M, Erker T, Felfe P, Fenyves A, Fescharek R, Frackenpohl C, Frahm AW, Frahm M, Franke V, Franken U, Geffken D, Geis U, Glusa E, Göber B, Gobina PN, Golder W, Goppelt-strübe M, Götte K, Gottstein E, Grosam M, von Gruchalla M, Gütschow M, Häfner A, Haluszczynski B, Harder A, Hartmann S, Hartmann S, Heber D, Heinemeyer G, Heller E, von Herrath D, Hilfenhaus J, Hoffmann-schollmayer U, Hofmann B, Holpert C, Hübner-steiner U, Inkmann E, Jürgens J, Kaiser B, Kalbhen D, Kemmler H, Kiefer W, Klett C, Klett S, Klingmüller M, Klöcking H, Kobal G, Kramer A, Kreher M, Krüger M, Kuhn M, Lehner MS, Leopoldt D, Liedtke G, Manns D, Matthiessen W, Maurer A, Meindl W, Menges K, Messinger P, Meyer FP, Meyerhof W, Moos M, Morgenstern R, Müller K, Müller WE, Nachtsheim C, Netzer T, Neugebauer M, Neupert W, Nickel P, Nuhn P, Nürnberg B, Oelschläger H, Oertel J, Oettel M, Oßwald H, Ott R, Ott T, Otzen T, Pachaly P, Pelzer H, Petersen K, Pick R, Pickert M, Pies A, Reimann E, Richter J, Riecke K, Ritter S, Rommelspacher H, Rose U, Roth G, Rücker G, Schäfer J, Schantl JG, Schlager H, Schleinitz H, Schmauß M, Schmidhammer H, Schmidt G, Schmidt T, Schneeweiß B, Schräder J, Schulz T, Schulze G, Schwanz P, Schweiger J, Skopp G, Skorka G, Smolinka K, Speck U, Stahlmann R, Stein H, Stiefvater K, Surborg K, Sürig U, Szelényi H, Szelenyi I, Täufel A, Thieroff-ekerdt R, Troschütz R, Verborg M, Verspohl EJ, Vogel S, Volk F, Vorwerk T, Wallmann J, Wenzel M, Weyandt-spangenberg M, Wich S, Wintersteiger R, Woltmann F, Wüst B, Zilow G, Kluge A. R. Hagers Handbuch der Pharmazeutischen Praxis 1999. [DOI: 10.1007/978-3-642-58388-9_7] [Reference Citation Analysis]
|
| 60 |
Bagchi D, Carryl OR, Tran MX, Bagchi M, Garg A, Williams CB, Milnes GG, Balmoori J, Bagchi DJ, Mitra S, Stohs SJ. Acute and chronic stress-induced oxidative gastrointestinal mucosal injury in rats and protection by bismuth subsalicylate. Stress Adaptation, Prophylaxis and Treatment 1999. [DOI: 10.1007/978-1-4615-5097-6_13] [Reference Citation Analysis]
|
| 61 |
Scott BB. Bismuth-containing single-antibiotic 1-week triple therapy for Helicobacter pylori eradication. Aliment Pharmacol Ther 1998;12:277-9. [PMID: 9570263 DOI: 10.1046/j.1365-2036.1998.00296.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 62 |
Pounder R. Gastrointestinal drugs. Side Effects of Drugs Annual 1998. [DOI: 10.1016/s0378-6080(98)80040-8] [Reference Citation Analysis]
|
| 63 |
Fine KD, Lee EL. Efficacy of open-label bismuth subsalicylate for the treatment of microscopic colitis. Gastroenterology 1998;114:29-36. [PMID: 9428215 DOI: 10.1016/s0016-5085(98)70629-8] [Cited by in Crossref: 141] [Cited by in F6Publishing: 148] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 64 |
Voet GBVD, Wolff FAD. Metals. Side Effects of Drugs Annual 1998. [DOI: 10.1016/s0378-6080(98)80026-3] [Reference Citation Analysis]
|
| 65 |
Pounder RE, Wyeth JW, Duggan AE, Bailey RJ, Louw JA, Ohlin B. Ranitidine bismuth citrate with clarithromycin for the eradication of Helicobacter pylori and for ulcer healing. Helicobacter 1997;2:132-9. [PMID: 9432341 DOI: 10.1111/j.1523-5378.1997.tb00074.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 66 |
Bagchi D, Carryl OR, Tran MX, Bagchi M, Vuchetich PJ, Krohn RL, Ray SD, Mitra S, Stohs SJ. Protection against chemically-induced oxidative gastrointestinal tissue injury in rats by bismuth salts. Dig Dis Sci 1997;42:1890-900. [PMID: 9331152 DOI: 10.1023/a:1018811210175] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 67 |
Savarino V, Mansi C, Mele MR, Bisso G, Mela GS, Saggioro A, Caroli M, Vigneri S, Termini R, Olivieri A, Tosatto R, Celle G. A new 1-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus two antibiotics. Aliment Pharmacol Ther 1997;11:699-703. [PMID: 9305478 DOI: 10.1046/j.1365-2036.1997.00202.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 68 |
Reed PI, Johnston BJ. Treatment of Helicobacter pylori infection. Biomed Pharmacother 1997;51:13-21. [PMID: 9084725 DOI: 10.1016/s0753-3322(97)87074-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
|
